Inventor · disambiguated record
Iriny Botrous
Also filed as: BOTROUS IRINY
8 granted patents·12 pending applications·141 citations·filing 2004–2025
86Inventor score
Top patents by PatentIndex Score
20 records- 0193US8106197B2Aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2006·Granted Jan 31, 2012·48 cites·11 claims
- 0292US7230098B2Aminoheteroaryl compounds as protein kinase inhibitorsSUGEN INC·Filed 2004·Granted Jun 12, 2007·73 cites·15 claims
- 0383US12145948B2Compounds and methods for modulating HER2IAMBIC THERAPEUTICS INC·Filed 2023·Granted Nov 19, 2024·1 cites·27 claims
- 0482US11434247B1Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Sep 6, 2022·2 cites·24 claims
- 0581US8114871B23-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivativesBOTROUS IRINY·Filed 2008·Granted Feb 14, 2012·6 cites·14 claims
- 0678US8999981B23-amido-pyrrolo[3,4-C]pyrazole-5(1H, 4H,6H) carbaldehyde derivativesBOTROUS IRINY·Filed 2012·Granted Apr 7, 2015·5 cites·12 claims
- 0778US2025145633A1Substituted furanopyrimidine compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0875US12006325B2Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Jun 11, 2024·0 cites·20 claims
- 0972US7250417B2Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitorsSUGEN INC·Filed 2004·Granted Jul 31, 2007·6 cites·8 claims
- 1071US2025276983A1Compounds and methods for modulating her2IAMBIC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1167US2024132521A1Compounds and methods for modulating her2IAMBIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1261US2022002309A1Ssao inhibitors and uses thereofMETACRINE INC·Filed 2019·Application pending·0 cites
- 1361US2024368127A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2022·Application pending·0 cites
- 1459US2020181104A1Ssao inhibitors and uses thereofMETACRINE INC·Filed 2020·Application pending·0 cites
- 1557US2024034736A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 1657US2024083861A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 1749US2023102554A1Heterocyclic kinase inhibitors and products and uses thereofGB002 INC·Filed 2020·Application pending·0 cites
- 1841US2019177327A1Substituted methyl pyrazolopyrimidinone and methyl imidazopyrazinone compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Application pending·0 cites
- 1938US2025276984A1Solid state forms of her2 inhibitorsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2036US2025345339A1Doses and regimens of her2 inhibitorsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Iriny Botrous files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →